Correlation Between Hypothekarbank Lenzburg and Relief Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hypothekarbank Lenzburg and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hypothekarbank Lenzburg and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hypothekarbank Lenzburg AG and Relief Therapeutics Holding, you can compare the effects of market volatilities on Hypothekarbank Lenzburg and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hypothekarbank Lenzburg with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hypothekarbank Lenzburg and Relief Therapeutics.

Diversification Opportunities for Hypothekarbank Lenzburg and Relief Therapeutics

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Hypothekarbank and Relief is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Hypothekarbank Lenzburg AG and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and Hypothekarbank Lenzburg is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hypothekarbank Lenzburg AG are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of Hypothekarbank Lenzburg i.e., Hypothekarbank Lenzburg and Relief Therapeutics go up and down completely randomly.

Pair Corralation between Hypothekarbank Lenzburg and Relief Therapeutics

Assuming the 90 days trading horizon Hypothekarbank Lenzburg AG is expected to under-perform the Relief Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Hypothekarbank Lenzburg AG is 22.44 times less risky than Relief Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Relief Therapeutics Holding is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  236.00  in Relief Therapeutics Holding on September 11, 2024 and sell it today you would earn a total of  139.00  from holding Relief Therapeutics Holding or generate 58.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.38%
ValuesDaily Returns

Hypothekarbank Lenzburg AG  vs.  Relief Therapeutics Holding

 Performance 
       Timeline  
Hypothekarbank Lenzburg 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hypothekarbank Lenzburg AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Hypothekarbank Lenzburg is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Relief Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Relief Therapeutics Holding are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Relief Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Hypothekarbank Lenzburg and Relief Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hypothekarbank Lenzburg and Relief Therapeutics

The main advantage of trading using opposite Hypothekarbank Lenzburg and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hypothekarbank Lenzburg position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.
The idea behind Hypothekarbank Lenzburg AG and Relief Therapeutics Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals